Coherus Oncology Inc

CHRSNASDAQ · USD
0.51USD0.00 (-3.73%)
322

Coherus Oncology Inc (CHRS) Implied Volatility Current

CHRS's 30 day implied volatility is 511.96%, with an IV Rank of 98.02%. This is a high IV Rank versus the past year, meaning Coherus Oncology Inc options are relatively expensive and currently favor sellers. CHRS's 30 day historical volatility sits at 132.75%, which means implied volatility is running 379.21 points above historical volatility, as of Nov 16, 2026.

Read more

Tracking CHRS implied volatility helps you spot when Coherus Oncology Inc options are historically cheap or expensive, and where the best trades are hiding. When CHRS IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor CHRS implied volatility current levels in real time and filter for high probability trades.

Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking CHRS IV rank helps you see whether CHRS's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.

Coherus Oncology, Inc., a biopharmaceutical company, researches, develops, and commercializes immunotherapies to treat cancer in the United States. The company develops UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte-colony stimulating factor; LOQTORZI, a novel next-generation programmed death receptor-1 inhibitor; and Casdozokitug, an investigational recombinant human immunoglobulin isotype (IgG1) monoclonal antibody targeting interleukin 27. It also develops CHS-114, an investigational highly specific human afucosylated IgG1 monoclonal antibody, a chemokine receptor highly expressed on Treg cells in the tumor microenvironment (TME); and CHS-1000, Anti-ILT4 monoclonal antibody for solid tumors.

Implied Volatility

IV Rank
98.02%IV Rank
High

IV is highly elevated. Premiums are expensive, strongly favoring sellers.

Implied Volatility (30d)511.96%

IV Rank98.02%

Historical Volatility (30d)132.75%

IV Minus HV+379.21%

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →